AGITATION
Clinical trials for AGITATION explained in plain language.
Never miss a new study
Get alerted when new AGITATION trials appear
Sign up with your email to follow new studies for AGITATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cannabis compound may calm agitation in dementia patients
Symptom relief OngoingThis study tests whether a combination of THC and CBD (compounds found in cannabis) can reduce agitation in people with dementia who are eligible for hospice care. About 120 participants will receive either the study drug or a placebo for 12 weeks. The main goal is to see if agit…
Matched conditions: AGITATION
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
ER agitation study halted before it began
Symptom relief TerminatedThis study aimed to see if a sublingual film of dexmedetomidine (BXCL501) could quickly reduce agitation in adults with bipolar disorder or schizophrenia visiting the emergency department. It was a single-arm pilot study, but it was withdrawn before enrolling any participants. No…
Matched conditions: AGITATION
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated May 18, 2026 12:13 UTC